The drug use
Drostanolone propionate was not approved by the FDA for use in men. In order to improve the physical or performance enhancing drug is usually administered by injection three times a week. weekly dose is generally 200 to 400 mg, and is received within 6-12 weeks. This dose is sufficient for a measurable increase in muscle mass and strength. To enhance the effect drostanolone propionate often combined with other injectable steroids such as Deka-Durabolin (nandrolone decanoate) or Equipoise is (boldenone undecylenate) providing muscle growth without excessive water retention. Steroids for building muscle often combined with injectable testosterone. The result is a faster growth of muscles, the low level of fluid retention and other estrogenic side effects when using these steroids alone. It is often combined with other steroids like Winstrol fragrances, Primobolan, Parabolan or Anavar, which helps maintain muscle mass graft and promotes fat loss, during a period which can be very catabolic without steroids.
However, in December 2004 the United States the 14-member Food and Drug Administration (FDA) advisory committee, plus voting consultants, for Reproductive Health Drugs unanimously rejected Procter and Gamble's fast-track request for Intrinsa citing concerns about off-label use . In Canada, post-menopausal women have been able to obtain government-approved testosterone treatment since 2002. In Australia, post-menopausal women can use Organon testosterone implants which have to be surgically inserted and last from three to six months. 
Many bodybuilders combine drostanolone with other AAS. [ citation needed ] Drostanolone itself is only weakly anabolic, which is why it is not used alone during bulking cycles. [ citation needed ] However, when combined with other anabolic steroids, drostanolone may enhance their effects. Also, drostanolone binds sex hormone-binding globulin (SHBG) which usually will bind a portion of free sex hormones and steroids, like testosterone, and inactivate them. When drostanolone binds to SHBG, the level of unbound SHBG drops, lowering the chance of it binding to other steroids, which increases their bioavailablilty.